Skip to main content

Table 4 Mean absorbed dose (Gy/GBq) per lesion of all patients

From: A head-to-head comparison between two commercial software packages for hybrid dosimetry after peptide receptor radionuclide therapy

  

Mono-exponential

Bi-exponential

Patient

Location

OLINDA/EXM

PLANET Dose

OLINDA/EXM

PLANET Dose

2

Liver

4.94

3.29

*

 

2

Liver

2.10

2.20

  

2

Liver

2.85

4.85

  

2

Other

5.85

5.72

  

3

Liver

5.05

5.02

5.05

3.09

3

Liver

1.63

1.54

1.92

1.56

3

Other

1.15

1.36

1.64

1.43

4

Liver

7.02

7.66

3.78

3.75

4

Liver

3.78

3.26

7.02

5.85

5

Liver

12.26

14.40

12.25

9.93

5

Liver

6.35

8.87

6.35

4.79

5

Other

3.89

3.71

3.89

3.85

5

Other

2.42

2.72

4.38

2.65

6

Other

1.71

1.31

3.05

1.33

7

Liver

5.10

5.57

5.10

4.92

7

Liver

5.13

6.05

5.13

4.85

7

Liver

7.29

7.45

7.29

8.09

7

Liver

3.94

5.48

3.94

4.40

7

Other

0.99

1.16

1.40

1.16

8

Liver

3.78

3.77

3.78

3.29

8

Liver

2.38

2.23

2.62

1.94

8

Liver

2.93

3.92

2.93

4.20

8

Liver

0.99

1.36

1.09

1.40

8

Liver

0.86

1.36

0.86

0.68

8

Other

3.00

3.28

3.18

3.20

9

Liver

0.87

1.09

0.87

1.07

9

Other

3.00

3.27

1.86

2.39

10

Liver

1.31

1.38

1.31

1.55

  1. *The dosimetric results of this patient were not reliable (very high dose values)